For research use only. Not for therapeutic Use.
Rupestonic acid(Cat No.:I018487)is a naturally occurring compound with notable anti-inflammatory and antioxidant properties. Derived from plants, it has gained attention in pharmaceutical research for its potential therapeutic applications in managing chronic inflammatory diseases and oxidative stress-related conditions. Studies suggest that Rupestonic acid may modulate key signaling pathways involved in immune response and cellular protection. It is also being explored for its ability to enhance wound healing and prevent tissue damage. Due to its promising biological activities, Rupestonic acid holds potential as a candidate for the development of novel therapeutic agents.
Catalog Number | I018487 |
CAS Number | 83161-56-2 |
Molecular Formula | C₁₅H₂₀O₃ |
Purity | ≥95% |
Target | Influenza Virus |
IUPAC Name | 2-[(5R,8S,8aS)-3,8-dimethyl-2-oxo-4,5,6,7,8,8a-hexahydro-1H-azulen-5-yl]prop-2-enoic acid |
InChI | InChI=1S/C15H20O3/c1-8-4-5-11(9(2)15(17)18)6-13-10(3)14(16)7-12(8)13/h8,11-12H,2,4-7H2,1,3H3,(H,17,18)/t8-,11+,12-/m0/s1 |
InChIKey | ZFHSKBJBODQVBX-AXTRIDKLSA-N |
SMILES | C[C@H]1CC[C@H](CC2=C(C(=O)C[C@@H]12)C)C(=C)C(=O)O |
Reference | [1]. Obul M, et al. Structural modification on rupestonic acid leads to highly potent inhibitors against influenza virus. Mol Divers. 2019 Feb;23(1):1-9. |